Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 70 articles:
HTML format
Text format



Single Articles


    July 2017
  1. HALLER M, Atkinson M, Schatz D
    More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403.
    PubMed     Text format    



  2. Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:405.
    PubMed     Text format    



  3. More on Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;377:403-5.
    PubMed     Text format    



  4. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed     Text format    


  5. MARTINEZ-CERON E, Garcia-Rio F
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300.
    PubMed     Text format    



  6. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;377:301.
    PubMed     Text format    



  7. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;377:300-301.
    PubMed     Text format    


  8. NATHAN DM, Bebu I, Lachin JM
    Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:195.
    PubMed     Text format    



  9. Frequency of Evidence-Based Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;377:194-195.
    PubMed     Text format    


  10. JANI SM, Nallamothu BK, Cooper LT, Smith A, et al
    Beating, Fast and Slow.
    N Engl J Med. 2017;377:72-78.
    PubMed     Text format    


    June 2017
  11. ARMSTRONG DG, Boulton AJM, Bus SA
    Diabetic Foot Ulcers and Their Recurrence.
    N Engl J Med. 2017;376:2367-2375.
    PubMed     Text format    


  12. NEAL B, Perkovic V, Mahaffey KW, de Zeeuw D, et al
    Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
    N Engl J Med. 2017 Jun 12. doi: 10.1056/NEJMoa1611925.
    PubMed     Text format     Abstract available


  13. MARSO SP, McGuire DK, Zinman B, Poulter NR, et al
    Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
    N Engl J Med. 2017 Jun 12. doi: 10.1056/NEJMoa1615692.
    PubMed     Text format     Abstract available


  14. FRALICK M, Schneeweiss S, Patorno E
    Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
    N Engl J Med. 2017;376:2300-2302.
    PubMed     Text format    


    May 2017
  15. ANKER MS, von Haehling S, Anker SD
    Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
    N Engl J Med. 2017;376:1996-7.
    PubMed     Text format    


  16. SCHAUER PR, Bhatt DL, Kashyap SR
    Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
    N Engl J Med. 2017;376:1997.
    PubMed     Text format    


  17. HOWARD DL
    Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
    N Engl J Med. 2017;376:1996.
    PubMed     Text format    


  18. SHUKLA AP, Aronne LJ
    Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
    N Engl J Med. 2017;376:1995-6.
    PubMed     Text format    


  19. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    PubMed     Text format     Abstract available


  20. BAIDAL DA, Ricordi C, Berman DM, Alvarez A, et al
    Bioengineering of an Intraabdominal Endocrine Pancreas.
    N Engl J Med. 2017;376:1887-1889.
    PubMed     Text format    


  21. SMITH TJ, Kahaly GJ, Ezra DG, Fleming JC, et al
    Teprotumumab for Thyroid-Associated Ophthalmopathy.
    N Engl J Med. 2017;376:1748-1761.
    PubMed     Text format     Abstract available


  22. RAMSEY BW, Nepom GT, Lonial S
    Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    N Engl J Med. 2017;376:1762-1769.
    PubMed     Text format    


    April 2017

  23. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed     Text format     Abstract available


  24. ROSENBERG JB, Tsui I
    Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;376:1587-1588.
    PubMed     Text format    


  25. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
    Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;376:1419-1429.
    PubMed     Text format     Abstract available


  26. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Text format     Abstract available


  27. INGELFINGER JR, Jarcho JA
    Increase in the Incidence of Diabetes and Its Implications.
    N Engl J Med. 2017;376:1473-1474.
    PubMed     Text format    


  28. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed     Text format    


    March 2017
  29. HUANG CS
    Fournier's Gangrene.
    N Engl J Med. 2017;376:1158.
    PubMed     Text format    


  30. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    PubMed     Text format    



  31. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    PubMed     Text format    


  32. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    PubMed     Text format    


  33. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    PubMed     Text format    



  34. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    PubMed     Text format    


    February 2017
  35. LUDVIGSSON J, Wahlberg J, Casas R
    Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;376:697-699.
    PubMed     Text format    


  36. SCHAUER PR, Bhatt DL, Kirwan JP, Wolski K, et al
    Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    N Engl J Med. 2017;376:641-651.
    PubMed     Text format     Abstract available


    December 2016
  37. MORAN-THOMAS A
    Breakthroughs for Whom? Global Diabetes Care and Equitable Design.
    N Engl J Med. 2016;375:2317-2319.
    PubMed     Text format    


  38. FERENCE BA, Robinson JG, Brook RD, Catapano AL, et al
    Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
    N Engl J Med. 2016;375:2144-2153.
    PubMed     Text format     Abstract available


    November 2016
  39. ANDERS HJ, Davis JM, Thurau K
    Nephron Protection in Diabetic Kidney Disease.
    N Engl J Med. 2016;375:2096-2098.
    PubMed     Text format    


  40. ALEGRE-DIAZ J, Herrington W, Lopez-Cervantes M, Gnatiuc L, et al
    Diabetes and Cause-Specific Mortality in Mexico City.
    N Engl J Med. 2016;375:1961-1971.
    PubMed     Text format     Abstract available


  41. GORDON CE, Vantzelfde S, Francis JM
    Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.
    N Engl J Med. 2016;375:2008-2009.
    PubMed     Text format    


  42. PAREEK A, Chandurkar N, Naidu K
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1800.
    PubMed     Text format    


  43. WAKISAKA M
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1799-1800.
    PubMed     Text format    



  44. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1799-1802.
    PubMed     Text format    


  45. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    PubMed     Text format    


  46. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    PubMed     Text format    



  47. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    PubMed     Text format    


  48. PARVING H-H, Lambers-Heerspink H, de Zeeuw D
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1800-1.
    PubMed     Text format    


  49. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    PubMed     Text format    


    October 2016
  50. HIROSE Y, Kaida H
    Emphysematous Pyelonephritis.
    N Engl J Med. 2016;375:1671.
    PubMed     Text format    


  51. MACDONALD SM, Rapalino O, Sherry NA, Cohen AB, et al
    Case 32-2016. A 20-Year-Old Man with Gynecomastia.
    N Engl J Med. 2016;375:1567-1579.
    PubMed     Text format    


  52. BYRNE TN, Stone JH, Pillai SS, Rapalino O, et al
    Case Records of the Massachusetts General Hospital. Case 31-2016. A 53-Year-Old Man with Diplopia, Polydipsia, and Polyuria.
    N Engl J Med. 2016;375:1469-1480.
    PubMed     Text format    



  53. Diabetic Sensory and Motor Neuropathy.
    N Engl J Med. 2016;375:1402.
    PubMed     Text format    


    September 2016
  54. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  55. PERSAUD SJ, Jones PM
    A Wake-up Call for Type 2 Diabetes?
    N Engl J Med. 2016;375:1090-2.
    PubMed     Text format    


  56. RAN M, Wang Y
    Generalized Granuloma Annulare Associated with Diabetes Mellitus.
    N Engl J Med. 2016;375:e21.
    PubMed     Text format    


  57. ZHANG L, Long J, Jiang W, Shi Y, et al
    Trends in Chronic Kidney Disease in China.
    N Engl J Med. 2016;375:905-6.
    PubMed     Text format    


  58. WANG HS, Shih MC
    Emphysematous Prostatitis.
    N Engl J Med. 2016;375:879.
    PubMed     Text format    


    August 2016
  59. STEWART ZA, Wilinska ME, Hartnell S, Temple RC, et al
    Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    N Engl J Med. 2016;375:644-54.
    PubMed     Text format     Abstract available


    July 2016

  60. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    PubMed     Text format     Abstract available


    June 2016
  61. MUSTAFA OM, Aduriz-Lorenzo PM
    IMAGES IN CLINICAL MEDICINE. Hypopyon and Klebsiella Sepsis.
    N Engl J Med. 2016;374:e33.
    PubMed     Text format    


  62. SAHIN M, Corapcioglu D
    Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available


  63. STANFORD FC, Alfaris N, Misra M
    Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available



  64. Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available


  65. WANNER C, Inzucchi SE, Lachin JM, Fitchett D, et al
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  66. INGELFINGER JR, Rosen CJ
    Cardiac and Renovascular Complications in Type 2 Diabetes - Is There Hope?
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  67. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  68. BAYRY J
    Repressing Immunity in Autoimmune Disease.
    N Engl J Med. 2016;374:2090-2.
    PubMed     Text format    


  69. KHONSARI RH, Ruhin B
    IMAGES IN CLINICAL MEDICINE. Loose Teeth and Excessive Thirst.
    N Engl J Med. 2016;374:e25.
    PubMed     Text format    


  70. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: